ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
28/06/2024
Voltar para busca
Dado oficial do USPTO
ACTIENT PHARMACEUTICALS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ACTIENT PHARMACEUTICALS
ST13
US500000077684190Classe
5
Pedido
77684190
Registro
4392464
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
89
Atualização mais recente
28/06/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
05/03/2009
Data de registro
27/08/2013
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/08/2023
Última transação
09/08/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2010-07-00
Primeiro uso no comércio
2010-07-00
Código do desenho
4
Tipo de titular
24
Localização do titular
BALLSBRIDGE, IE
Examinador
SONNEBORN, TRICIA L
Unidade examinadora
M10
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
ENDO OPERATIONS LIMITED
ACTIENT PHARMACEUTICALS LLC
ACTIENT PHARMACEUTICALS LLC
Actient Pharmaceuticals, Inc.
Actient Pharmaceuticals, Inc.
Representantes
Camille M. Miller Cozen O'Connor
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationstestosterone supplements and preparations for the treatment of erectile dysfunctionemphysema and chronic bronchitisheart diseasehypertensionrelief of pain and the relief of symptoms associated with season allergic rhinitis
Publicações
Histórico de despachos e eventos da marca no USPTO.
89 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/05/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/08/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/08/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/08/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
28/06/2023
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
20/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/03/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
31/08/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27/08/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
22/12/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/09/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/09/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2018
E815
TEAS SECTION 8 & 15 RECEIVED
27/08/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27/08/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/06/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/06/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/02/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/11/2013
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/11/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
27/08/2013
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/07/2013
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
25/07/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23/07/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/07/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/07/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/06/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/06/2013
CNRT
NON-FINAL ACTION MAILED
29/01/2013
CNRT
SU - NON-FINAL ACTION - WRITTEN
29/01/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/01/2013
IUAF
USE AMENDMENT FILED
19/12/2012
EISU
TEAS STATEMENT OF USE RECEIVED
19/12/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
08/06/2012
EX5G
SOU EXTENSION 5 GRANTED
07/06/2012
DPCC
DIVISIONAL PROCESSING COMPLETE
07/06/2012
EXT5
SOU EXTENSION 5 FILED
24/05/2012
DRRR
DIVISIONAL REQUEST RECEIVED
24/05/2012
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
24/05/2012
EEXT
SOU TEAS EXTENSION RECEIVED
24/05/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
13/01/2012
EX4G
SOU EXTENSION 4 GRANTED
12/01/2012
EXT4
SOU EXTENSION 4 FILED
30/12/2011
EEXT
SOU TEAS EXTENSION RECEIVED
30/12/2011
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/12/2011
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
30/12/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
02/07/2011
EX3G
SOU EXTENSION 3 GRANTED
01/07/2011
EXT3
SOU EXTENSION 3 FILED
27/06/2011
EEXT
SOU TEAS EXTENSION RECEIVED
27/06/2011
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/02/2011
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
18/02/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/02/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
07/01/2011
EX2G
SOU EXTENSION 2 GRANTED
05/01/2011
EXT2
SOU EXTENSION 2 FILED
05/01/2011
EEXT
SOU TEAS EXTENSION RECEIVED
05/01/2011
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/12/2010
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/11/2010
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/11/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
03/08/2010
EX1G
SOU EXTENSION 1 GRANTED
02/08/2010
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/08/2010
EXT1
SOU EXTENSION 1 FILED
02/07/2010
EEXT
SOU TEAS EXTENSION RECEIVED
02/07/2010
CHPB
POST PUBLICATION AMENDMENT - ENTERED
11/05/2010
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
15/04/2010
PCGR
PETITION TO DIRECTOR GRANTED
15/04/2010
APET
ASSIGNED TO PETITION STAFF
23/03/2010
PCRC
PETITION TO DIRECTOR RECEIVED
29/01/2010
PAPER RECEIVED
29/01/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/01/2010
PUBO
PUBLISHED FOR OPPOSITION
13/10/2009
NPUB
NOTICE OF PUBLICATION
23/09/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/09/2009
ALIE
ASSIGNED TO LIE
08/09/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2009
CNEA
EXAMINERS AMENDMENT MAILED
02/09/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
02/09/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/09/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/06/2009
CNRT
NON-FINAL ACTION MAILED
01/06/2009
CNRT
NON-FINAL ACTION WRITTEN
01/06/2009
DOCK
ASSIGNED TO EXAMINER
28/05/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2009
NWAP
NEW APPLICATION ENTERED
09/03/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACTIENT PHARMACEUTICALS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.